Table 2.
Differences in bone parameters between patients with T2DM and controls.
| DXA-Derived Parameters | T2DM (n = 126) |
Controls (n = 117) |
p Value |
|---|---|---|---|
| Lumbar spine BMD (g/cm2) | 1.010 ± 0.165 | 0.937 ± 0.161 | 0.031 |
| Lumbar spine T-score | −0.620 ± 1.258 | −0.787 ± 1.524 | 0.359 |
| Total hip BMD (g/cm2) | 0.936 ± 0.131 | 0.891 ± 0.145 | 0.080 |
| Total hip T-score | −0.384 ± 0.961 | −0.491 ± 1.132 | 0.801 |
| Femoral neck BMD (g/cm2) | 0.744 ± 0.125 | 0.725 ± 0.119 | 0.391 |
| Femoral neck T-score | −1.002 ± 1.137 | −1.213 ± 0.903 | 0.373 |
| TBS | 1.180 ± 0.112 | 1.209 ± 0.120 | 0.060 |
| Individuals with degraded bone architecture (TBS ≤ 1.23) |
62.7% | 59.5% | 0.61 |
| Individuals with partially degraded bone architecture (1.23 < TBS ≤ 1.31) |
30.2% | 22.4% | 0.17 |
| Individuals with normal bone architecture (TBS > 1.31) |
7.1% | 18.1% | 0.01 |
Data are shown as mean values ± standard deviation (SD) or percentages. Abbreviations: BMD: bone mineral density; DXA: dual-energy X-ray absorptiometry; TBS: trabecular bone score; T2DM: type 2 diabetes mellitus.